<DOC>
	<DOCNO>NCT00362713</DOCNO>
	<brief_summary>The purpose study learn ipilimumab give safely two different dos give patient urothelial cancer go surgery part treatment . The immunological effectiveness ipilimumab also study .</brief_summary>
	<brief_title>Study Neoadjuvant Ipilimumab Patients With Urothelial Carcinoma Undergoing Surgical Resection</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Previously untreated urothelial cancer require surgery treatment Ineligible chemotherapy Adequate hematologic , kidney liver function Sexually active fertile individual partner individual unwilling unable use acceptable method birth control entire trial 4 week study Women pregnant breastfeed Women positive pregnancy test enrollment prior study drug administration Prior treatment ipilimumab antiCTLA4 antibody , CD137 agonist Concurrent malignancy , exception adequately treat cured basal squamous cell skin cancer , carcinoma situ cervix ( previous malignancy without evidence disease 5 year also allow enter trial ) Autoimmune disease : subject document history inflammatory bowel disease ( include Crohn 's disease ulcerative colitis ) exclude study patient history symptomatic disease ( e.g. , rheumatoid arthritis , systemic progressive sclerosis [ scleroderma ] , Systemic Lupus Erythematosus , autoimmune vasculitis [ e.g. , Wegener 's Granulomatosis ] ) . Subjects motor neuropathy consider autoimmune origin ( e.g. , GuillainBarre Syndrome ) exclude study Patients deem ineligible surgery Any nononcology vaccine therapy use prevention infectious diseased past month Concomitant therapy following : IL2 , interferon nonstudy immunotherapy regimen , chemotherapy ; immunosuppressive agent ; investigation therapy ; chronic use systemic corticosteroid ( used management cancer noncancer relate illness ) Prior radiation therapy urothelial cancer Positive screening test prior history HIV , Hepatitis B Hepatitis C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>